MolNFT v1 · #54991 · protein
The discovery of MMP7 inhibitors exploiting a novel selectivity trigger
2Y6C · Matrilysin: “The discovery of MMP7 inhibitors exploiting a novel selectivity trigger”. X-ray diffraction, 4 ligands (TQI, CA, ZN), 1 pocket (best druggability 0.43). MolNFT v1 #54991 on GenesisL1: 3D structure, binding sites and…
- PDB
- 2Y6C
- Type
- protein
- Length
- 161 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Matrilysin
- EC
- 3.4.24.23
- UniProt
- P09237
- Ligands
- TQI, CA, ZN, SO4
- Pockets
- 1 · best druggability 0.43
Structure
x-ray diffraction · 1 distinct chain · 24% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Matrilysin (EC 3.4.24.23) | protein | 161 | 24% helix, 18% strand | P09237 |
Ligands and binding sites
- TQI · N-{[4-chloro-3-(trifluoromethyl)phenyl]sulfonyl}-L-tryptophan · ligand · chains A
- CA · Calcium ion · metal · 2 copies · chains A
- ZN · Zinc ion · metal · 2 copies · chains A
- SO4 · Sulfate ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 85 | 0.43 | 0.79 | 19 | TQI |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P09237
- Elsewhere: RCSB PDB 2Y6C · PDBe 2Y6C · UniProt P09237
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.